Dr. Sheng-Xiao Zhang is an Associate Professor specializing in Internal Medicine, particularly in the field of Rheumatology and Autoimmunity. He holds a Ph.D. and serves as an Attending Physician at The Second Hospital of Shanxi Medical University. Dr. Zhang’s research focuses on evidence-based medicine, drug repurposing, and immune regulation in rheumatic diseases. He has made significant contributions to the field through his extensive academic achievements, publications, and collaborative efforts.
Author Metrics
Dr. Zhang’s research has garnered substantial recognition, with a citation index of 689 in prominent databases such as Scopus, Web of Science, and PubMed. His publications have a cumulative impact factor of 300.3 over the last three years, reflecting the influence of his work in the scientific community. Additionally, his H-index, based on bibliometrics from Scopus and Web of Science, stands at 15, underscoring the significance of his contributions to the field.
Scopus Profile
ORCID Profile
Citations: Zhang Shengxiao’s work has received 662 citations from 587 documents.
Documents: Zhang Shengxiao has authored 77 documents.
h-index: The h-index, a metric reflecting both the productivity and impact of a researcher’s publications, is 15 for Zhang Shengxiao.
Education
Dr. Zhang received his Bachelor’s, Master’s, and Doctoral degrees from Shanxi Medical University, specializing in Clinical Medicine. His educational background provided a solid foundation for his subsequent research and professional endeavors in rheumatology and autoimmunity.
Research Focus
Dr. Zhang’s research primarily revolves around understanding the immune dysregulation mechanisms in rheumatic diseases, particularly focusing on peripheral blood CD4+ T cell subsets. He investigates the role of regulatory T cells (Treg) and their potential in modulating disease activity. Furthermore, his work delves into drug repurposing strategies aimed at restoring immune tolerance and ameliorating clinical symptoms in patients with rheumatic diseases.
Professional Journey
Throughout his career, Dr. Zhang has held various academic and clinical positions, including serving as an Associate Professor at Shanxi Medical University’s Second Clinical Medical College and as an Attending Physician in the Department of Rheumatology and Immunology at The Second Hospital of Shanxi Medical University. He has also contributed as a Visiting Scholar at Tsinghua University’s School of Medicine, showcasing his dedication to advancing medical knowledge through collaboration and exchange.
Honors & Awards
Dr. Zhang has received numerous accolades for his contributions to research and teaching, including prestigious awards such as the BEST ABSTRACT AWARDS from the Asia-Pacific League of Associations for Rheumatology Congress. He has also been recognized for his excellence in mentoring and teaching, highlighting his commitment to nurturing the next generation of medical professionals.
Publications Noted & Contributions
Dr. Zhang’s publications are notable for their impact on the field of rheumatology and autoimmunity. His groundbreaking research on peripheral blood CD4+ T cell subsets and immune regulation mechanisms has been published in renowned journals, contributing significantly to the understanding and treatment of rheumatic diseases. His review articles, such as “Exploring the therapeutic potential of regulatory T cells in rheumatoid arthritis,” provide valuable insights into potential therapeutic strategies for these conditions.
Title: “Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis”
- Journal: Frontiers in Immunology
- Year: 2024
- DOI: 10.3389/fimmu.2024.1312919
- Contributors: Zhang, J.; Liu, H.; Chen, Y.; Liu, H.; Zhang, S.; Yin, G.; Xie, Q.
Title: “Dysbiosis of the Gut Microbiota in Patients with Psoriatic Arthritis is Closely Related to Lymphocyte Subsets and Cytokines”
- Journal: Inflammation
- Year: 2024
- DOI: 10.1007/s10753-024-01971-1
- Contributors: Liu, J.; Zhang, S.-X.; Zhao, R.; Song, S.; Zhang, H.-Y.; Wang, C.-H.; Li, X.-F.
Title: “Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
- Journal: Rheumatology and Therapy
- Year: 2024
- DOI: 10.1007/s40744-024-00638-5
- Contributors: Su, Q.-Y.; Zhou, H.-N.; Xia, G.-M.; Zhang, R.-Y.; Tian, H.-Y.; Su, C.; Liu, Y.-X.; Zhang, H.-Y.; Cheng, T.; Huo, Y.-H. et al.
Title: “Efficacy, Safety and the Lymphocyte Subset Changes of Low-Dose IL-2 in Patients with Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis”
- Journal: Rheumatology and Therapy
- Year: 2024
- DOI: 10.1007/s40744-023-00620-7
- Contributors: Su, Q.; Wang, X.; Li, Y.; Zhang, J.; Bai, C.; Wang, X.; Yang, L.; Zhang, J.; Zhang, S.-X.
Title: “Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: A systematic review and meta-analysis”
- Journal: Immunity, Inflammation and Disease
- Year: 2024
- DOI: 10.1002/iid3.1165
- Contributors: Su, Q.-Y.; Luo, J.; Wang, X.-M.; Di, J.-K.; Cao, Y.-X.; Zhang, S.-X.
Research Timeline
Dr. Zhang’s research timeline spans over five years, during which he has completed nine research projects and presented his findings at numerous conferences. His cumulative impact factor and citation index reflect the impact and recognition his research has garnered in the scientific community.
Collaborations and Projects
Dr. Zhang actively collaborates with researchers and institutions worldwide, participating in joint publications and projects aimed at advancing knowledge in rheumatology and autoimmunity. His collaborations extend beyond academia, with involvement in consultancy projects and industry-sponsored initiatives aimed at translating research findings into clinical practice.
